Literature DB >> 33453330

MAFLD: A holistic view to redefining fatty liver disease.

Mohammed Eslam1, Jacob George2.   

Abstract

Entities:  

Year:  2021        PMID： 33453330     DOI： 10.1016/j.jhep.2020.12.027

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  6 in total

1.  Metabolic-associated Fatty Liver Disease.

Authors:  Ming-Hua Zheng
Journal:  J Clin Transl Hepatol       Date:  2021-11-09

2.  Characterization of microbiome and metabolite analyses in patients with metabolic associated fatty liver disease and type II diabetes mellitus.

Authors:  Qiuping Yang; Leisheng Zhang; Qian Li; Man Gu; Qiu Qu; Xinglong Yang; Qinghua Yi; Kunli Gu; Linli Kuang; Mei Hao; Jing Xu; Hongju Yang
Journal:  BMC Microbiol       Date:  2022-04-15       Impact factor: 4.465

3.  Waiting for Multi-Stakeholders'Consensus Position Statement on New Nonalcoholic Fatty Liver Disease Nomenclature.

Authors:  Eileen L Yoon; Dae Won Jun
Journal:  Gut Liver       Date:  2022-05-15       Impact factor: 4.519

Review 4.  Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.

Authors:  Natalia Vallianou; Gerasimos Socrates Christodoulatos; Irene Karampela; Dimitrios Tsilingiris; Faidon Magkos; Theodora Stratigou; Dimitris Kounatidis; Maria Dalamaga
Journal:  Biomolecules       Date:  2021-12-31

Review 5.  From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights.

Authors:  Alexandra Gatzios; Matthias Rombaut; Karolien Buyl; Joery De Kock; Robim M Rodrigues; Vera Rogiers; Tamara Vanhaecke; Joost Boeckmans
Journal:  Biomedicines       Date:  2022-01-12

Review 6.  Quantitative assessment of liver steatosis using ultrasound controlled attenuation parameter (Echosens).

Authors:  Giovanna Ferraioli
Journal:  J Med Ultrason (2001)       Date:  2021-06-16       Impact factor: 1.314
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.